CAMK2N1, whose transcript levels are increased in primary PC yet downregulated in CRPC [62, 63] and whose downregulation predicts poor clinical outcome [64], encodes functions that suppress tumor invasiveness [65] and androgen-independent proliferation [66]. The gene discussed is CAMK2N1; the disease is neoplasm.